163 related articles for article (PubMed ID: 2010229)
1. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
4. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
6. [Tumor diagnosis by immunoscintigraphy with anti-CEA antibodies (Tc-99m MAK BW 431/26)].
Kroiss A; Tuchmann A; Schüller J; Weiss W; Wirth M; Auinger C; Neumayr A
Wien Klin Wochenschr; 1989 Sep; 101(18):621-6. PubMed ID: 2815778
[TBL] [Abstract][Full Text] [Related]
7. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
9. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
Goldenberg DM; Wegener W
Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
[TBL] [Abstract][Full Text] [Related]
10. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM
Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706
[TBL] [Abstract][Full Text] [Related]
12. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
13. [99mTc anti-carcinoembryonic antigen in colorectal cancer].
Frederiksen PB; Rasmussen JW; Lassen E; Fenger C; Kronborg O; Ditzel H
Ugeskr Laeger; 1994 Mar; 156(11):1641-5. PubMed ID: 8009660
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
[TBL] [Abstract][Full Text] [Related]
15. Anti-CEA labelling kit BW 431/26. Results of the European multicenter trial.
Steinsträsser A; Oberhausen E
Nuklearmedizin; 1995 Dec; 34(6):232-42. PubMed ID: 8596740
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
17. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
Yao YF; Yang Z; Li ZF; Gu J
World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
19. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
20. 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results.
Baum RP; Hertel A; Lorenz M; Schwarz A; Encke A; Hör G
Nucl Med Commun; 1989 May; 10(5):345-52. PubMed ID: 2662074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]